Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Tayba Alawadi"'
Autor:
Dudley Tarlton, Sultana Al-Sabahi, Nicholas Banatvala, Khalifa Elmusharaf, Yahya M Al-Farsi, Daniel Grafton, Johanna S Jung, Lamia Mahmoud, Rebecca Gribble, Sébastien Poix, Rachael Stanton, Deena Hamza Al Asfoor, Tayba Alawadi, Mohammed Mustafa, Lulwa Shuwaiter, Mohammed S Alsuwaidan, Zahir Al-Abri, Sherif Fadda, Hassan Raza Syed, Muneera Almutairi
Publikováno v:
BMJ Open, Vol 14, Iss 6 (2024)
Objective While the Gulf Cooperation Council (GCC) countries have demonstrated a strong commitment to strengthening primary healthcare (PHC), the costs of delivering these services in this region remain relatively unexplored. Understanding the costs
Externí odkaz:
https://doaj.org/article/ed88a8e9b6964afa845fba800f8ab091
Autor:
Mohammed Albreiki, Mira Mousa, Syafiq Kamarul Azman, Hema Vurivi, Zainab Alhalwachi, Fatima Alshehhi, Safiya AlShamsi, Nada Al Marzouqi, Tayba Alawadi, Hussain Alrand, Abderrahim Oulhaj, Asma Fikri, Habiba Alsafar
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionA rapid increase in COVID-19 cases due to the spread of the Delta and Omicron variants in vaccinated populations has raised concerns about the hospitalization risk associated with, and the effectiveness of, COVID-19 vaccines.MethodThis ca
Externí odkaz:
https://doaj.org/article/c7f232c829da4962a3e43b663b8abfdb
Autor:
Mira Mousa, Mohammed Albreiki, Fatima Alshehhi, Safiya AlShamsi, Nada Al Marzouqi, Tayba Alawadi, Hussain Alrand, Habiba Alsafar, Asma Fikri
Publikováno v:
Journal of travel medicine. 29(6)
Inactivated vaccine BBIBP-CorV {Sinopharm; 95% [95% confidence interval (CI): 94, 97%]} and the mRNA vaccine BNT162b2 [Pfizer-BioNTech; 98% (95% CI: 86, 99%)] demonstrated protection against COVID-19 related hospitalizations from the Delta (B.1.617.2